Doisne, J.M. et al. Skin and peripheral lymph node invariant NKT cells are mainly retinoic acid receptor-related orphan receptor (gamma)t+ and respond preferentially under inflammatory conditions. J. Immunol. 183, 2142-2149

INSERM Unité 561/Groupe AVENIR, Hôpital Cochin St Vincent de Paul, Université Descartes, Paris, France.
The Journal of Immunology (Impact Factor: 5.36). 09/2009; 183(3):2142-9. DOI: 10.4049/jimmunol.0901059
Source: PubMed

ABSTRACT Lymph nodes (LNs) have been long considered as comprising few invariant NKT (iNKT) cells, and these cells have not been studied extensively. In this study, we unravel the existence of stable rather than transitional LN-resident NK1.1(-) iNKT cell populations. We found the one resident in peripheral LNs (PLNs) to comprise a major IL-17-producing population and to express the retinoic acid receptor-related orphan receptor (gamma)t (ROR(gamma)t). These cells respond to their ligand alpha-galactosylceramide (alpha-GalCer) in vivo by expanding dramatically in the presence of LPS, providing insight into how this rare population could have an impact in immune responses to infection. PLN-resident ROR(gamma)t(+) NK1.1(-) iNKT cells express concomitantly CCR6, the integrin alpha-chain alpha(E) (CD103), and IL-1R type I (CD121a), indicating that they might play a role in inflamed epithelia. Accordingly, skin epithelia comprise a major ROR(gamma)t(+) CCR6(+)CD103(+)CD121a(+) NK1.1(-) cell population, reflecting iNKT cell composition in PLNs. Importantly, both skin and draining PLN ROR(gamma)t(+) iNKT cells respond preferentially to inflammatory signals and independently of IL-6, indicating that they could play a nonredundant role during inflammation. Overall, our study indicates that ROR(gamma)t(+) iNKT cells could play a major role in the skin during immune responses to infection and autoimmunity.

Download full-text


Available from: Gerard Eberl, Oct 22, 2014
  • Source
    • ". In psoriatic patients, these γδ T cells were greatly increased in affected skin and produced large amounts of IL-17 [59]. Attention could also be paid to RORγt+, CCR6+, CD4neg, NK1.1neg iNKT cells [60] as a potential source of IL-17 in psoriasis, since these cells have been also described in skin and draining lymph nodes and respond to inflammatory signals in mice [61]. Beside the Th17 cells, a so-called Th22 subpopulation producing IL-22 but nor IL-17 or IFNγ has been recently "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cutaneous homeostasis and defenses are maintained by permanent cross-talk among particular epidermal keratinocytes and immune cells residing or recruited in the skin, through the production of cytokines. If required, a coordinated inflammatory response is triggered, relayed by specific cytokines. Due to numerous reasons, troubles in the resolution of this phenomenon could generate a cytokine-mediated vicious circle, promoting skin chronic inflammation, the most common being atopic dermatitis and psoriasis. In this paper, we discuss the biological effects of cytokine on keratinocytes, more particularly on specific or shared cytokines involved in atopic dermatitis or psoriasis. We report and discuss monolayer or 3D in vitro models of keratinocytes stimulated by specific sets of cytokines to mimic atopic dermatitis or psoriasis. IL-22, TNFa, IL-4, and IL-13 combination is able to mimic an "atopic dermatitis like" state. In psoriasis lesions, over expression of IL-17 is observed whereas IL-4 and IL-13 were not detected; the replacement of IL-4 and IL-13 by IL-17 from this mix is able to mimic in vitro a "psoriasis like" status on keratinocytes. We conclude that specific cytokine environment deregulation plays a central role on skin morphology and innate immunity, moving towards specific pathologies and opening the way to new therapeutic strategies.
    Journal of Allergy 11/2012; 2012:718725. DOI:10.1155/2012/718725
  • Source
    • "Although both innate and adaptive IL‑17‑producing cells express the master transcription factor Rorγt, the differentiation and regulatory factors seem to differ between innate and adaptive cells. Most studies show a requirement for IL‑6 signalling in T H 17 development, but notably IL‑6 is irrelevant for the development and maintenance of IL‑17‑producing γδ T cells as well as iNKT cells (Doisne et al, 2009; Martin et al, 2009). How the differentiation of IL‑17‑producing innate lymphocytes is regulated "
    [Show abstract] [Hide abstract]
    ABSTRACT: Interleukin-17 (IL-17)-mediated immune responses play a crucial role in the mucosal host defence against microbial and fungal pathogens. However, the chronic activation of IL-17-producing T helper cells can cause autoimmune disease. In addition, recent studies have highlighted key roles of innate cell-mediated IL-17 responses in various inflammatory settings. Besides inflammation, there have also been intriguing findings regarding the involvement of IL-17 responses in the pathogenesis of cardiovascular diseases and tumour formation. Here, we discuss the latest discoveries in regulation and function of innate and adaptive IL-17-producing cells.
    EMBO Reports 12/2011; 13(2):113-20. DOI:10.1038/embor.2011.248 · 7.86 Impact Factor
  • Source
    • "Six-to eight-week-old male or female C57BL/6, myd88 2/2 mice were obtained from the authors' own laboratory (Kawai et al., 1999). Six-to eight-week-old male or female C57BL/6 IL-6 2/2 mice were obtained from Gérard Eberl (Institut Pasteur, Paris, France) (Doisne et al., 2009). All animal experiments were performed in compliance with the recommendations of the French Ministry of Agriculture and were approved by the French Veterinary Services (accreditation no. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Finding two or more genotypes of a single species within an infected sample is a not infrequent event. In this work, three Escherichia coli strains of decreasing extra-intestinal virulence (pathogenic B2S and B1S strains, and the avirulent K-12 MG1655 strain) were tested in septicaemia and urinary tract infection (UTI) mouse models, either separately or in pairs. Survival was monitored and bacteria were counted in various organs. Serum interleukin (IL)-6, tumour necrosis factor alpha (TNFα) and IL-10 were measured. We show that a mix of high amounts of B1S or of MG1655 with low amounts of B2S killed more rapidly (B1S), or killed more mice (MG1655), than either high amounts of B1S, high amounts of MG1655 or low amounts of B2S separately in the mouse septicaemia model. This bacterial synergy persisted when high amounts of dead or abnormal-LPS K-12 cells were injected together with a low amount of B2S. In both septicaemia and UTI models, significantly more bacteria were recovered from the organs of mice injected with the MG1655/B2S mix than from those of mice injected with the inocula separately. Consistently, in the septicaemia model, more IL-6 was secreted before death by the mice that were injected with the mix of bacteria than by the mice that were injected with the inocula separately. The synergistically enhanced mortality in the case of co-infection in the septicaemia model persisted in RFcγ(-/-), Myd88(-/-) and IL-6(-/-) knockout mice. This synergistically increased virulence resulting from the interaction between an avirulent and a pathogenic strain of the same bacterial species raises questions about the role of avirulent bacteria in the development of some extra-intestinal infections.
    Microbiology 11/2010; 157(Pt 3):774-85. DOI:10.1099/mic.0.037416-0 · 2.84 Impact Factor
Show more